We studied the properties of N6-chloroadenosine phosphates (ATP, ADP, and AMP chloramines) as compounds with potentially increased antiplatelet efficacy determined by their binding to the plasma membrane of platelets. Chloramine derivatives of ATP, ADP, and AMP do not differ in their optical absorption characteristics: their absorption spectra are in the range of 220-340 nm with a maximum at 264 nm. Chloramines of adenosine phosphates are characterized by high reactivity with respect to thiol compounds. In particular, the rate constants of the reaction of N6-chloroadenosine-5’-diphosphate with N-acetylcysteine, reduced glutathione, dithiothreitol, and cysteine reach 59,000, 250,000, 340,000, and 1,250,000 M—1×sec—1, respectively, and only 1.10±0.02 M—1×sec—1 with methionine. It has been found that N6-chloradenosine-5’-triphosphate is a strong inhibitor of platelet functions: it effectively suppresses ADP-induced cell aggregation (IC50 in the whole blood is 5 μM) and inhibits aggregation of preactivated platelets and induces dissociation of their aggregates.
Similar content being viewed by others
References
Davies MJ, Hawkins CL, Pattison DI, Rees MD. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid. Redox Signal. 2008;10(7):1199-1234. doi: https://doi.org/10.1089/ars.2007.1927
Murina MA, Fesenko OD, Sergienko VI, Chudina NA, Roshchupkin DI. Antithrombotic Activity of N,N-Dichlorotaurine on Mouse Model of Thrombosis in Vivo. Bull. Exp. Biol. Med. 2002;.134(1):36-38. doi: https://doi.org/10.1023/A:1020600520233
Murina MA, Roshchupkin DI, Kondrashova KV, Sergienko VI. Inhibition of plasma coagulation and platelet aggregation with structural analogs of taurine chloramine. Bull. Exp. Biol. Med. 2014;157(2):207-210. doi: https://doi.org/10.1007/s10517-014-2526-9
Lebon G, Warne T, Edwards PC, Bennett K, Langmead CJ, Leslie AG, Tate CG. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature. 2011;474:521-525. doi: https://doi.org/10.1038/nature10136
Murina MA, Roshchupkin DI, Sergienko VI. The antiplatelet effect and chemical activity of N6-chloroadenosine phosphate. Biophysics. 2021;66(4):535-540. doi: https://doi.org/10.1134/S0006350921040151
Altomare A, Baron G, Brioschi M, Longoni M, Butti R, Valvassori E, Tremoli E, Carini M, Agostoni P, Vistoli G, Banfi C, Aldini G. N-Acetyl-Cysteine Regenerates Albumin Cys34 by a Thiol-Disulfide Breaking Mechanism: An Explanation of Its Extracellular Antioxidant Activity. Antioxidants (Basel). 2020;9(5):367. doi: https://doi.org/10.3390/antiox9050367
Samuni Y, Goldstein S, Dean OM, Berk M. The chemistry and biological activities of N-acetylcysteine. Biochim. Biophys. Acta. 2013;1830(8):4117-4129. doi: https://doi.org/10.1016/j.bbagen.2013.04.016
Luo D, Smith SW, Anderson BD. Kinetics and mechanism of the reaction of cysteine and hydrogen peroxide in aqueous solution. J. Pharm. Sci. 2005;94(2):304-316. doi: https://doi.org/10.1002/jps.20253
Fritsma GA, McGlasson DL. Whole Blood Platelet Aggregometry. Methods Mol. Biol. 2017;1646:333-347. doi: https://doi.org/10.1007/978-1-4939-7196-1_26
Aslam M, Sedding D, Koshty A, Santoso S, Schulz R, Hamm C, Gündüz D. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y1 and P2Y12 receptors. Thromb. Res. 2013;132(5):548-557. doi: https://doi.org/10.1016/j.thromres.2013.08.021
Zhang K, Zhang J, Gao ZG, Zhang D, Zhu L, Han GW, Moss SM, Paoletta S, Kiselev E, Lu W, Fenalti G, Zhang W, Müller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature. 2014;509:115-118. doi: https://doi.org/10.1038/nature1308
Sugidachi A, Ohno K, Ogawa T, Jakubowski J, Hashimoto M, Tomizawa A. A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats. Br. J. Pharmacol. 2013;169(1):82-89. doi: https://doi.org/10.1111/bph.12108
Ferri N, Corsini A, Bellosta S. Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. Drugs. 2013;73(15):1681-1709. doi: https://doi.org/10.1007/s40265-013-0126-z
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 175, No. 2, pp. 161-165, February, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Murina, M.A., Roshchupkin, D.I. & Sergienko, V.I. Antiplatelet Action of Chloramine Derivatives of Adenosine Phosphates and Their Chemical Activity in Relation to Sulfur-Containing Compounds. Bull Exp Biol Med 175, 201–204 (2023). https://doi.org/10.1007/s10517-023-05834-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05834-x